Robert Califf : leading cardiologist is new FDA Deputy Commissioner

被引：1

|

作者：

Jaffe, Susan

机构：

来源：

LANCET | 2015年 / 385卷 / 9970期

关键词：

D O I：

10.1016/S0140-6736(15)60425-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：765 / 765

页数：1

相关论文

共 41 条

[31] FDA Commissioner Hamburg builds agency's capabilities for bringing new therapies to patients
Wechsler, Jill
FORMULARY, 2010, 45 (02) : 69 - 70
[32] Crawford seeks to restore confidence in FDA approval process - Drug safety and access top the priority list for new FDA commissioner
不详
FORMULARY, 2005, 40 (08) : 257 - 257
[33] Robert Adam and His Brothers: new light on Britain's leading architectural family
Miele, Chris
ANTIQUARIES JOURNAL, 2023, 103 : 465 - 467
[34] Robert Adam and his Brothers. New Light on Britain's leading architectural, family
Robey, Ann
TRANSACTIONS OF THE ANCIENT MONUMENTS SOCIETY, 2020, 64 : 159 - 160
[35] Patient enrollment per month (accrual) in clinical trials leading to the FDA approval of new cancer drugs
Albers, S.
Michaeli, J. C.
Michaeli, C. T.
Michaeli, D. T.
ANNALS OF ONCOLOGY, 2024, 35 : S527 - S527
[36] Patient Enrollment per Month (Accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs
Michaeli, Daniel Tobias
Michaeli, Thomas
Albers, Sebastian
Michaeli, Julia Caroline
TARGETED ONCOLOGY, 2024, 19 (05) : 797 - 809
[37] Robert Williams ("Bobby") Brown, MD, cardiologist - Major league baseball player (New York Yankee), and American league president: A conversation with the editor
Roberts, William Clifford
Brown, Robert William
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (05): : 715 - 742
[38] Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety
Swinney, David C.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (05) : 461 - 478
[39] Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety.
Swinney, DC
FASEB JOURNAL, 2006, 20 (04): : A267 - A267
[40] Consensus Report of a Joint NCI Thoracic Malignancies Steering Committee: FDA Workshop on Strategies for Integrating Biomarkers into Clinical Development of New Therapies for Lung Cancer Leading to the Inception of "Master Protocols" in Lung Cancer
Malik, Shakun M.
Pazdur, Richard
Abrams, Jeffrey S.
Socinski, Mark A.
Sause, William T.
Harpole, David H., Jr.
Welch, John J.
Korn, Edward L.
Ullmann, Claudio Dansky
Hirsch, Fred R.
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : 1443 - 1448

← 1 2 3 4 5 →